Humana Inc.

NYSE:HUM Rapport sur les actions

Capitalisation boursière : US$42.2b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Humana Croissance future

Future contrôle des critères 2/6

Humana devrait augmenter ses bénéfices et son chiffre d'affaires de 19.1% et de 4.3% par an respectivement. Le BPA devrait croître de de 21.1% par an. Le rendement des capitaux propres devrait être 15.5% dans 3 ans.

Informations clés

19.1%

Taux de croissance des bénéfices

21.1%

Taux de croissance du BPA

Healthcare croissance des bénéfices19.4%
Taux de croissance des recettes4.3%
Rendement futur des capitaux propres15.5%
Couverture par les analystes

Good

Dernière mise à jour13 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Aug 19
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact

Jul 24

Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Jul 16
Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Jun 23

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Jun 20
Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Jun 06
Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Humana Is Set Up For Long-Term Success

Jun 05

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

May 21
Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Apr 22
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Apr 20
Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana: Where To Buy This

Apr 02

Humana: This Year's Drop Might Have Created A Buying Opportunity

Mar 19

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Feb 03

Humana: The $300 Level Could Get Taken Out In The Near Future

Jan 25

Humana: My Oh My, Another Strong Buy

Jan 14

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Jan 02

Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Dec 14
Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Humana: Failed Merger And Other Reasons To Buy

Dec 11

Humana: Upgrade To Buy

Oct 06

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Sep 27

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Aug 25
We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana: Mr. Market Got This One Right

Aug 03

Humana: Recent Selloff Might Present A Buying Opportunity

Jul 13

Humana: Rising Medical Costs Should Be Temporary

Jun 28

Humana: Margin Expansion Supported By Growing Memberships

Jun 12

Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

May 26
Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Apr 13
Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Humana Q4 2022 Earnings Preview

Jan 31

Humana: Destined For A Long-Term Success

Jan 23

Humana (NYSE:HUM) Could Easily Take On More Debt

Jan 13
Humana (NYSE:HUM) Could Easily Take On More Debt

Humana receives $70.85B contract from Defense Health Agency

Dec 22

Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?

Dec 20
Are Investors Undervaluing Humana Inc. (NYSE:HUM) By 34%?

Humana: Top-Rated Medicare Advantage Insurer With Room To Grow

Nov 14

Humana prices $1.23B debt offering

Nov 08

Humana Q3 2022 Earnings Preview

Nov 01

Humana expands partnership with Cohere Health on prior authorization services

Oct 24

Humana announces major expansion of Florida Dental Network, benefits

Oct 17

Prévisions de croissance des bénéfices et des revenus

NYSE:HUM - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026123,8102,9043,4534,45015
12/31/2025116,5652,2762,7263,48019
12/31/2024115,7371,7202,0982,31020
6/30/2024112,0361,711-5,054-4,246N/A
3/31/2024109,2431,991-3,241-2,283N/A
12/31/2023106,3742,4892,9773,981N/A
9/30/2023102,3513,0154,9925,988N/A
6/30/202398,7273,37812,13913,189N/A
3/31/202395,6423,1159,90710,972N/A
12/31/202292,8702,8063,4504,587N/A
9/30/202291,4852,8078,3859,618N/A
6/30/202290,5123,1432,7294,000N/A
3/31/202287,4953,0352,0803,401N/A
12/31/202183,0642,9339202,262N/A
9/30/202182,2012,6731,4002,641N/A
6/30/202180,4502,4824561,621N/A
3/31/202178,8883,7223,2664,328N/A
12/31/202077,1553,3674,6755,639N/A
9/30/202074,3884,1534,9705,868N/A
6/30/202070,5543,5025,6376,495N/A
3/31/202067,7162,6144,0734,862N/A
12/31/201964,8882,7074,5485,284N/A
9/30/201962,7612,5503,7574,439N/A
6/30/201960,7262,505306942N/A
3/31/201958,7401,758-1,234-617N/A
12/31/201856,9121,6831,5612,173N/A
9/30/201855,9331,512-989-405N/A
6/30/201855,0091,3672,9503,513N/A
3/31/201854,2841,824N/A3,532N/A
12/31/201753,7672,448N/A4,051N/A
9/30/201753,4561,863N/A4,189N/A
6/30/201753,8681,814N/A5,829N/A
3/31/201754,3411,475N/A5,639N/A
12/31/201654,379614N/A1,936N/A
9/30/201654,8621,116N/A5,046N/A
6/30/201654,531980N/A1,575N/A
3/31/201654,2561,100N/A1,263N/A
12/31/201554,2891,276N/A868N/A
9/30/201553,2561,320N/A724N/A
6/30/201552,1311,296N/A646N/A
3/31/201550,6211,209N/A1,054N/A
12/31/201448,5001,147N/A1,618N/A
9/30/201446,359972N/A1,409N/A
6/30/201444,4401,050N/A1,602N/A
3/31/201442,5391,126N/A1,975N/A
12/31/201341,3131,231N/A1,716N/A
9/30/201340,6831,453N/A1,937N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de HUM ( 19.1% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de HUM ( 19.1% par an) devraient croître plus rapidement que le marché US ( 15.1% par an).

Croissance élevée des bénéfices: Les bénéfices de HUM devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de HUM ( 4.3% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de HUM ( 4.3% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de HUM devrait être faible dans 3 ans ( 15.5 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y